Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 58Neoplasms 52Lung Neoplasms 33Colorectal Neoplasms 28Carcinoma, Non-Small-Cell Lung 25Prostatic Neoplasms 22Melanoma 19Pancreatic Neoplasms 17Ovarian Neoplasms 16Uterine Cervical Neoplasms 14Sarcoma 12Multiple Myeloma 12Lymphoma 11Glioma 11Glioblastoma 11Neoplasm Metastasis 10Leukemia, Myeloid, Acute 10Colonic Neoplasms 10Neoplastic Cells, Circulating 9Hematologic Neoplasms 9Lymphoma, Follicular 8Head and Neck Neoplasms 8Leukemia 7Carcinoma, Hepatocellular 7Brain Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Papillomavirus Infections 6Myelodysplastic Syndromes 6Endometrial Neoplasms 6Disease 6

Interventions

Lenalidomide 4Gemcitabine 4Dexamethasone 4Cyclophosphamide 4Bortezomib 4Nivolumab 3Cisplatin 3Carboplatin 3vandetanib 2tumor necrosis factor-alpha, CNGRC fusion protein, human 2pomalidomide 2pembrolizumab 2liposomal doxorubicin 2fludarabine 2durvalumab 2capivasertib 2Paclitaxel 2Doxorubicin 2Bevacizumab 2venetoclax 1umbralisib 1ublituximab 1tremelimumab 1tivozanib 1ricolinostat 1regorafenib 1pazopanib 1niraparib 1nilotinib 1neratinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Disease Progression × Blood Specimen Collection × Clear all
NCT07560865 2026-05-01

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Masonic Cancer Center, University of Minnesota

Phase 1 Recruiting
9 enrolled
CNS

Astrocytoma, Glioblastoma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡